Jennifer S Guimbellot
Arkansas Children's Hospital Research Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jennifer S Guimbellot as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:15 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07148739 · Ensuring Access to Optimal Therapy in CF: The ENACT StudyArkansas Children's Hospital Research Institute · recruiting · Cystic Fibrosis (CF) · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:15 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- ENsuring ACcess to optimal Therapy in CF: ENACT studyR01HL171034 · NHLBI · ARKANSAS CHILDREN'S HOSPITAL RES INST · fiscal years 2024 to 2026 · $569,850 awarded in 2026Grant number is on one of their registry trials
- Evaluating Maternal and Neonatal Pharmacokinetics of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators - The ELECTRA Pregnancy StudyR01HD117940 · NICHD · ARKANSAS CHILDREN'S HOSPITAL RES INST · fiscal years 2025 to 2026 · $635,230 awarded in 2026Same name and institution; not confirmed by an ID
- Pharmacometric approaches to precision optimization of ivacaftor response in cystic fibrosis patientsK23HL143167 · NHLBI · ARKANSAS CHILDREN'S HOSPITAL RES INST · fiscal years 2020 to 2024 · $150,012 awarded in 2024Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.